Ansa Biotechnologies Raises $71.5 Million To Scale DNA Synthesis
By Amit Chowdhry ● Today at 9:32 AM
Ansa Biotechnologies has raised $71.5 million in an oversubscribed Series C round, bringing its total funding to $211 million. Blue Water Life Science Advisors led the financing. New investors included Illumina Ventures, BEVC, Lightscape Partners, and Agent Capital. Existing investors Cerberus Ventures, Fall Line Capital, Dauntless Ventures, and Altitude Life Science Ventures also participated.